US clinical stage biopharma Candel Therapeutics (Nasdaq: CADL) has announced final survival data from a Phase IIa clinical ...

Scottish gut health specialist EnteroBiotix has announced positive initial results with EBX-102-02, its full-spectrum microbiome product, from the TrIuMPH Phase IIa trial in adults with irritable ...

Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the first patient has been dosed in its Phase IIa trial of ALY-101 in patients suffering from Alopecia ...

Dubai, UAE: The Internal Audit Department of Dubai Electricity and Water Authority (DEWA) has received a ‘Generally Conforms’ rating in a review conducted by the UAE chapter of the Internal Auditors ...

Infinitopes, a pioneering precision immuno-oncology company, today announced the appointments of Dan Menichella and Jo Brewer, PhD as Non-Executive Directors to its Board as the company prepares to ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Kentucky battered Texas A&M’s starting pitching for the third consecutive day and won a series against the Aggies in College Station for the second time in three trips, earning a 10-5 victory on ...

Lucara Diamond Corp. ("Lucara" or the "Company") today announced a strategic change in the management of its Karowe underground project ("UGP") in Botswana. The Company has terminated its Engineering, ...

Credit: elenavolf / Shutterstock. Perfuse Therapeutics has reported 24-week data from its first-in-human, multi-centre Phase I/IIa trial of the PER-001 intravitreal implant for individuals with ...